VVOS - Vivos Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Vivos Therapeutics, Inc.
IPO Date: July 7, 2020
Sector: Healthcare
Industry: Medical Devices
Market Cap: $3.01M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.19 | 6.06%
Avg Daily Range (30 D): $0.02 | 8.17%
Avg Daily Range (90 D): $0.03 | 7.13%
Institutional Daily Volume
Avg Daily Volume: 1.43M
Avg Daily Volume (30 D): 21.48M
Avg Daily Volume (90 D): 8.97M
Trade Size
Avg Trade Size (Sh.): 358
Avg Trade Size (Sh.) (30 D): 732
Avg Trade Size (Sh.) (90 D): 648
Institutional Trades
Total Institutional Trades: 25
Avg Institutional Trade: $.96M
Avg Institutional Trade (30 D): $.65M
Avg Institutional Trade (90 D): $.65M
Avg Institutional Trade Volume: .03M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $1.05M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $.84M
Avg Closing Volume: 12.46K
 
News
Aug 25, 2026 @ 12:45 PM
Vivos Therapeutics Reports Record New Patient Refe...
Source: Na
Jun 8, 2026 @ 5:39 PM
Vivos Therapeutics To Participate in the Small Cap...
Source: Na
Jan 21, 2026 @ 6:00 PM
Global Sleep Apnea Devices Market is Expected to C...
Source: Delveinsight
Jan 20, 2026 @ 10:31 PM
Vivos Therapeutics Announces Closing of Exercise o...
Source: Na
Dec 15, 2025 @ 10:30 PM
Vivos Therapeutics to Participate in Online Firesi...
Source: Vivos Therapeutics, Inc.
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-1.9 $-.31 $-.52
Diluted EPS $-1.9 $-.31 $-.52
Revenue $20.9M $5.15M $5.14M
Gross Profit $12.94M $2.95M $3.06M
Net Income / Loss $-25.63M $-5.52M $-7.75M
Operating Income / Loss $-22.56M $-4.83M $-6.62M
Cost of Revenue $7.96M $2.2M $2.08M
Net Cash Flow $-2.63M $-.26M $M
PE Ratio    
Splits
Oct 27, 2023 1:25